Quarter Financials
NGM Biopharmaceuticals, Inc. (NGM)
$16.64
-0.06 (-0.36%)
Income Statement
Balance Sheet
Cash Flow
|
Year
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
2021 Q2
|
2021 Q1
|
2020 Q4
|
2020 Q3
|
|---|
| Net Income | -47 | -32 | - | -29 | -37 | -28 | -28 | -30 |
|---|
| Dividend Paid | - | - | - | - | - | - | - | - |
|---|
| Retained Earnings | -498 | -451 | - | -392 | -363 | -326 | -299 | -271 |
|---|
|
Year
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
2021 Q2
|
2021 Q1
|
2020 Q4
|
2020 Q3
|
|---|
| Capital Expenditure | -1 | -0 | -0 | -0 | -1 | -0 | -0 | -0 |
|---|
| Net PPE | 12 | 13 | - | 11 | 13 | 14 | 15 | 16 |
|---|
|
Year
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
2021 Q2
|
2021 Q1
|
2020 Q4
|
2020 Q3
|
|---|
| New Purchases | - | -148 | -145 | -50 | - | -99 | -87 | -57 |
|---|
| Intangible and Goodwill | - | - | - | - | - | - | - | - |
|---|